PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase
Open Access
- 19 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (3), 862-867
- https://doi.org/10.1182/blood-2006-07-028829
Abstract
Elucidation of the molecular mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes. One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homology 2 (SH2) domains (Shp2). This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis. More recently, somatic missense PTPN11 gain-of-function mutations have been detected in leukemias and rarely in solid tumors, and have been found to induce aberrant hyperactivation of the Ras-Erk pathway. This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the molecular mechanisms underlying cell transformation.Keywords
This publication has 87 references indexed in Scilit:
- Germline Missense Mutations Affecting KRAS Isoform B Are Associated with a Severe Noonan Syndrome PhenotypeAmerican Journal of Human Genetics, 2006
- Germline KRAS mutations cause Noonan syndromeNature Genetics, 2006
- Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human DiseaseAmerican Journal of Human Genetics, 2006
- Germline mutations in HRAS proto-oncogene cause Costello syndromeNature Genetics, 2005
- Diverse Biochemical Properties of Shp2 MutantsJournal of Biological Chemistry, 2005
- A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathyEuropean Journal of Pediatrics, 2005
- Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemiaJournal of Human Genetics, 2005
- Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndromeJournal of Medical Genetics, 2005
- Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorderBlood, 2004
- Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancersNature Genetics, 2002